Vertical: HealthcareBase Year: 201811 Sections
Market Size (2018)
$3.18B
Projected (2025)
$4.99B
CAGR (2016–2025)
6.8%
Key Players
10+
Ambulatory monitoring devices are an extremely important advancement in cardiac monitoring technology. Wearable ambulatory monitoring devices present several advantages over conventional ECG machines. Conventional ECG machines can record the heart rhythm up to 12 seconds, where-as ambulatory monitors can continuously track the heart rhythm for extended periods ranging from 24 hours to several months and sometimes up to 2 to 3 years. Also, wearable ambulatory monitors help doctors diagnose intermittent cardiac arrhythmias that occur only infrequently and irregularly. Such arrhythmias are unpredictable, produce sudden symptoms, and are no longer present by the time the patient reaches to the doctor. Hence these arrhythmias are impossible to diagnose using the standard ECG. Ambulatory monitors are attached to the patient’s body for days, weeks, or even years which greatly increases the chance of capturing such intermittent but potentially significant arrhythmias.
The Wearable Ambulatory Monitoring Devices Market market is projected to grow at a CAGR of 6.8% from 2016 to 2025.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansWearable ambulatory monitoring devices are small, portable electrocardiograph machines that are used to record the heart’s rhythm. These ambulatory monitors are either attached externally to the patient’s body or are inserted below the skin of the patient. Each type of monitor has unique features in terms of the length of the recording time of the heart rhythm and its ability to transmit the data to the receiver’s device. The selection of ambulatory monitoring devices is made upon assessment of the patient’s condition and the doctors prescribe the appropriate monitoring devices to the patient.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2018
Historical Period
2016 – 2017
Forecast Period
2019 – 2025
Primary Interviews
150+
Historical data (2016–2018) and forecast period (2018–2025)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThe global wearable ambulatory monitoring devices market is characterized by the presence of many global, regional, and local vendors. The market is highly competitive, with all players competing to gain a substantial presence in the market. Intense competition, rapid advances in technology, frequent changes in government policies, and regulations are key factors that confront market growth. The manufacturers compete based on cost, quality, and reliability. It is decisive for the manufacturers to provide cost-efficient and high-quality products to survive and succeed in an intensely competitive and growing market environment.
The growth of market vendors is dependent on market conditions, government support, and industry development. Thus, manufacturers should focus on expanding geographically and improving their products. They primarily focus on the development of novel products. Although international players are dominating the market, regional, and foreign players with small market shares also have a considerable presence. The international players may strengthen their presence worldwide through acquisitions and mergers during the forecast period. In addition, improvement of the global economic scenario combined with efforts to enhance infrastructure in emerging nations is fueling the market growth, thereby making it an ideal time for new players with innovative products to enter the market and increase the global market share.
The global wearable ambulatory monitoring market consists of a large number of global and local players operating in the respective regions. Although the market is quite scattered with no clear leaders in the market, there are few players that have captured significant market share in the global wearable ambulatory monitoring devices market.
With respect to the current scope of the report, GE healthcare is observed to be the top player in the global wearable ambulatory monitoring devices market owing to its strong distribution channel and wide geographic presence. In 2018, GE healthcare held a 23.4% market share in the global market. Medtronic PLC is the second major player with a 13.1% share followed by Biotelemetry which held a 10.6% share in 2018 in the global wearable ambulatory monitoring devices market.
Threat of New Entrants
The threat of new entrants in the global wearable ambulatory monitoring devices market is high. Any company trying to enter the market is required to accept the mandatory regulatory standards issued by government authorities. However, ambulatory monitoring devices involve simple portable medical devices. Thus, a large number of local players are involved in manufacturing these ambulatory monitoring devices. Although the market consists of established medical device companies and brands, no player has complete dominance over the market. The prescription and usage of the ambulatory monitoring devices depend on the commercial availability of the product and its cost. New entrants in the market primarily focus on launching the products at aggressive pricing to compete with the big players. All these factors encourage new market players to enter into the business and capture the market share.
Bargaining Power of Suppliers
In the global wearable ambulatory monitoring devices market, suppliers are raw material providers and small component providers. There are several suppliers present in the market owing to the high demand, increasing government support, and the availability of huge opportunities for the development of the market. The switching cost of these suppliers is high because suppliers tend to enter into long-term associations, partnerships, and deals with other device manufacturing companies. Also, the key companies thrive to survive in the market with their brand identity and the quality of the product. Therefore, the overall bargaining power of suppliers in the global wearable ambulatory monitoring devices market is medium.
Threat of Substitutes
The threat of substitutes in the global wearable ambulatory monitoring devices market is low. Heart monitoring is an extremely important aspect of patient care in patients suffering from cardiovascular diseases. Over the period, highly advanced monitors have been introduced in the market. However, all the existing cardiac monitoring technologies are still being used and is not substituted by the new ones. In terms of accuracy of the data, there are hardly any substitutes available in the market such as standalone ECG monitors. Thus, the threat of substitutes replacing the wearable ambulatory monitoring devices is quite low.
Bargaining Power of Buyers
The bargaining power of buyers is medium to high in the global wearable ambulatory monitoring devices market. This is increasing due to a rise in the number of choices of the products and low switching costs for the buyers. Thus, several manufacturers are trying to come up with innovative techniques along with competitive pricing to withstand the competition. Also, the end user’s inclination towards innovative products in the market irrespective of the brand value are shifting the bargaining power of the buyers in the industry.
Intensity of Rivalry
The degree of competition in the global wearable ambulatory monitoring devices market is high. Companies involved in this market are trying to introduce more advanced equipment for differentiating their product from their rivals. Moreover, manufacturers also focus on the enhanced safety and quality of the devices to increase the demand for these products in developed countries as well as in developing regions. To overcome the competition, players are engaged in partnering with established organizations.
Market estimates by geography (2025)
InsightAmericas leads with $1.96B by 2025, while Asia Pacific is projected to grow fastest at a 7.4% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2016 | 2018 | 2025 | CAGR | SHARE |
|---|---|---|---|---|---|
| Middle East and Africa | $253.70M | $358.30M | $419.70M | 5.8% | 8% |
| Americas | $1.08B | $1.56B | $1.96B | 6.8% | 39% |
| Asia Pacific | $607.30M | $843.10M | $1.16B | 7.4% | 23% |
| Europe | $818.60M | $1.17B | $1.45B | 6.6% | 29% |
| Total | $2.76B | $3.93B | $4.99B | 6.8% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$4.99B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Cardiac Event Monitors | $1.90B | 6.8% | 38% |
| Holter Monitor | $1.12B | 6.9% | 22% |
| Others | $1.09B | 7.1% | 22% |
| Mobile Cardiac Telemetry Devices | $879.90M | 6.3% | 18% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Wearable Ambulatory Monitoring Devices Market covering market dynamics, competitive landscape, and strategic outlook.
The Wearable Ambulatory Monitoring Devices Market market is projected to reach $4.99B by 2025, growing at 6.8% CAGR. The Cardiac Event Monitors segment holds the largest share.
Wearable ambulatory monitoring devices are used to monitor the patient’s heart rates and provide the patient data to healthcare professionals through the wireless network. The growing prevalence rate of cardiac diseases, increasing demand for ambulatory monitoring devices, coupled with quick and enhanced diagnostics of cardiovascular diseases, is expected to enhance the growth of the market. However, the increasing number of product recalls and complications related to devices are projected to curb the growth of the market.
Coronary heart diseases, strokes, transient ischemic attack (TIA), peripheral arterial disease, and aortic diseases are some of the common types of cardiovascular diseases (CVD). Smoking, high cholesterol level, high blood pressure, tobacco, physical inactivity, unhealthy diet, alcohol, overweight, and obesity are some of the common causes of CVDs. According to the Centers for Disease Control and Prevention (CDC) in 2017, over 18.2 million adults in the US aged 20 and above had coronary heart disease. The data also states that in 2017, about 805,000 Americans had a heart attack. As per the statistics published by the American College of Cardiology Foundation in 2019, coronary heart disease events are expected to occur in about 1 million individuals in the US, including 335,000 recurrent and 720,000 new coronary events.
A similar rise in the number of heart diseases has been observed in other parts of the world. For instance, according to the British Heart Foundation, about 1.4 million people in the UK have been diagnosed with Atrial Fibrillation as of December 2019, and about 1 in every six patients is not treated effectively. This creates demand for monitoring the disease and thereby is expected to boost the demand for wearable ambulatory monitoring devices.
As the prevalence of chronic cardiovascular conditions keeps on rising, the continuous monitoring of patients with heart diseases is extremely crucial. Here-in, cardiac monitoring devices play an integral part in monitoring patients and avoiding the risk of heart failure and other associated risks. Annually, over 795,000 Americans have a new or recurrent stroke. Among these patients, 90% are observed to have a stroke due to modifiable risk factors and 74% due to behavioral risk factors. These risk factors can be detected earlier by wearable ambulatory monitoring devices by tracking the physiologic changes to notice early detection of CVDs. Thus, the growing prevalence of cardiac diseases is expected to increase the demand and use of ambulatory monitoring devices which thereby provides a favorable scenario for the market to grow over the forecast period.
The increasing innovation in the wearable ambulatory monitoring devices market is expected to largely affect the growth of the market during the assessment period. For instance, in November 2017, BioTelemetry, the US manufacturer of medical devices, came in partnership with Apple Inc. to provide cardiac monitoring services in combination with Apple Heart Study. This partnership is an initiative to benefit the individuals who are unaware that they might be at risk of serious health problems. In May 2018, GE Healthcare announced the collaboration with Preventice Solutions to provide an integrated solution to in-house ECG, long-term Holter, cardiac event monitoring (CEM), and mobile cardiac telemetry (MCT), which will result in a single portal utilizing the GE Healthcare MUSE cardiac management system. Thus, the growing worldwide demand for precise monitoring devices influences key players to create more and more innovation in the near future. As a result, this will lead to the growth of the wearable ambulatory monitoring devices market.
Furthermore, smart algorithms and Artificial Intelligence (AI) are entering into the market to support the diagnosis further. AI will operate in the background of the monitoring software, continuously reviewing real-time patient data, and quickly studying days or weeks of recorded data in seconds. This will likely be a big help in triggering CVD events. Thus, the advancements in technology such as support of AI in cardiology to speed up the therapy and potentially cut the time needed to monitor the patients is expected to create an opportunity for market growth during the forecast period.
The increase in product recalls in recent years has impacted the growth of wearable ambulatory monitoring devices negatively. For instance, in February 2016, Medtronic PLC announced the recall of its Reveal LINQ Insertable Cardiac Monitor (ICM) in Australia. This recall was classified under Class II as it might cause temporary or medically reversible adverse health consequences in patients. Such incidences affect the sales of other brands of companies, which results in decreased growth for the company, as well as a decrease in the growth for the whole market.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 105 companies operating in the Wearable Ambulatory Monitoring Devices Market market, including revenue, employee count, and market positioning where available.
Showing 105 of 105 companies
Company Headquarters: Pennsylvania, US Founded: 1994 Workforce: ~1,600 Company Working: BioTelemetry provides monitoring services and digital population health management to healthcare providers. It also develops and manufactures medical devices and centralized core laboratory services for clinical research. The company is focused on cardiac monitoring and has developed a proprietary integrated patient management platform to transmit data through the wireless network. It has three business segments, namely, healthcare, research, and technology.
Company Headquarters: Massachusetts, US Founded: 1983 Workforce: ~1,001-5,000 Company Working: ZOLL Medical Corporation develops and markets software solutions and medical devices, which aids in advance emergency care with increasing clinical and operational efficiency. The major products delivered by the company are circulation and CPR feedback, data management, therapeutic temperature management, defibrillation & monitoring, and ventilation. It also provides a comprehensive set of technologies that aid clinicians, emergency medical services, patients, and others. ZOLL Medical Corporation is a subsidiary of Asahi Kasei Group.
Company Headquarters: Florida, US Founded: 1981 Workforce: ~51-200 Company Working: Medicomp Inc. develops, manufactures, and provides ambulatory heart-monitoring systems across the globe. The company has been at the forefront of the cardiac telemedicine industry with patented technologies such as ambulatory devices with unified analysis & reporting software and on-site diagnostic systems. The company is committed to advancing science in patient monitoring.
Company Headquarters: California, US Founded: 1981 Workforce: ~51-200 Company Working: ACS Diagnostics provides external counterpulsation (ECP) therapy and Holter monitoring instruments in the US. ECP therapy is a non-invasive treatment that relieves angina or chest pain. It also offers impedance cardiograph instruments, ultrasound systems, instrument management systems, remote assistance instruments, and related accessories. It is renowned for its Holter monitoring products and is also a recognized manufacturer of external counterpulsation machines.
Hill-Rom Services Inc. — Healthcare
Coty is a fragrance-led global beauty company and, by its own description, one of the world's largest beauty groups, with FY2026 net revenues of USD 5.81bn split roughly two-thirds Prestige (licensed and owned luxury fragrance, prestige cosmetics and skincare — Burberry, Hugo Boss, Calvin Klein, Chloé, Marc Jacobs, Davidoff, Kylie Cosmetics, Gucci until mid-2027) and one-third Consumer Beauty (mass color cosmetics such as CoverGirl, Rimmel, Max Factor and Sally Hansen; mass fragrance; and Brazilian body care). Its core competitive asset is an end-to-end fragrance platform — licensing, innovation, ~81% in-house manufacturing and global prestige distribution — that has produced blockbuster franchises such as Burberry Goddess. After five years of deleveraging under Sue Nabi, Coty entered 2026 in a reset: revenue and margins are declining, the Gucci licence exits a year early, mass color and Brazil are under strategic review, and new interim leadership is executing a "Coty.Curated" focus-and-simplify framework with leverage of 3.4x. --- **Company's own description (paraphrased from FY2026 10-K, Item 1).** Coty describes itself as one of the world's largest beauty companies with an iconic brand portfolio across fragrance, color cosmetics, and skin and body care. It states that it is focused on leveraging its leadership position and capabilities in global fragrances to fuel expansion, strengthening its presence in a limited number of structurally profitable and growing categories, and prioritising growth channels such as e-commerce and Travel Retail. Under the Coty.Curated framework it emphasises fewer, bigger initiatives, marketing sufficiency, supply reliability, consumer advocacy, more productive innovation and portfolio choices, a return to market-share growth, and AI-powered, data-driven operations. It is also evaluating its central organisation, manufacturing and asset base to resize after the Gucci exit. **What the company does.** Coty designs, manufactures (≈81% in-house, ≈19% via third-party manufacturers in FY2026), markets and distributes beauty products. The essential oils in its fragrances are generally sourced from specialist fragrance houses; Coty owns the brand development, juice selection/briefing, bottle and packaging design, filling and assembly, marketing and commercial execution. Principal raw materials are essential oils, alcohols and specialty chemicals (10-K FY2026). **Business model and revenue model.** **Value-chain position.** Coty sits between ingredient suppliers (fragrance houses, alcohol and packaging suppliers) and retailers. Its economic moat lies in (i) licence portfolio scale in prestige fragrance, (ii) innovation and launch capability (brief-to-shelf), and (iii) owned manufacturing in the U.S., Europe and Brazil. It is structurally exposed to licensors (who own the trademarks) and to concentrated retailers (Sephora, Ulta, Douglas, Walmart, drug chains, travel-retail operators). **End markets.** Prestige fragrance (core), prestige cosmetics (Kylie Cosmetics, Marc Jacobs Beauty, Gucci Beauty until FY2027), prestige skincare (Lancaster, philosophy), mass color cosmetics, mass fragrance and mists, mass skin & body care (concentrated in Brazil). **Independent characterisation.** Coty is effectively two businesses with very different economics: a high-quality, licence-dependent prestige fragrance franchise generating ~20% adjusted EBITDA margins (Prestige FY2026 adjusted EBITDA margin 20.5% per Q4 FY2026 call), and a structurally challenged mass color cosmetics/Brazil business whose segment adjusted EBITDA margin collapsed to the low single digits in FY2026 (derived). The 2025–2026 strategic actions (Wella exit, Gucci monetisation, Consumer Beauty review) are converting Coty into a narrower fragrance pure-play with lower leverage but higher licence concentration.
8 interactive charts drawn from the Wearable Ambulatory Monitoring Devices Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Wearable Ambulatory Monitoring Devices Market Germany, Spain, France, United Kingdom, Italy, Eastern-Europe, Western-Europe and Rest Of Western Europe Of Europe By Country
Global Wearable Ambulatory Monitoring Devices Market Australia, China, India, Japan, South Korea and Rest Of Asia Pacific By Country
Global Wearable Ambulatory Monitoring Devices Market Middle-East and Africa Of Middle East And Africa
Global Wearable Ambulatory Monitoring Devices Market By Region
Wearable Ambulatory Monitoring Devices Market Europe
Wearable Ambulatory Monitoring Devices Market Asia Pacific By Country
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Mn)
